USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c

Despite of advances in treatment options, hepatocellular carcinoma (HCC) remains nearly incurable and has been recognized as the third leading cause of cancer-related deaths worldwide. As a deubiquitinating enzyme, the antitumor effect of ubiquitin-specific peptidase 53 (USP53) has been demonstrated...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Ye, Ma, Weijie, Guo, Yonghua, Liu, Yingyi, Xia, Peng, Wu, Xiaoling, Chen, Yiran, Wang, Kunlei, Mei, Chengjie, Wang, Ganggang, Li, Xiaomian, Zhang, Zhonglin, Chen, Xi, Yuan, Yufeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163188/
https://www.ncbi.nlm.nih.gov/pubmed/35654790
http://dx.doi.org/10.1038/s41389-022-00404-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163188/
https://www.ncbi.nlm.nih.gov/pubmed/35654790
http://dx.doi.org/10.1038/s41389-022-00404-8

Ejemplares similares